Daily US Conference Calendar - 9th October 2026: MS

This is a routine conference calendar rather than a market-moving item, and days of this kind historically pass without index-level consequence. The distinction that matters inside such schedules is between sell-side conferences, where management commentary tends to stay within existing guidance, and medical or clinical meetings, where small-cap pharma and biotech names have on past occasions repriced sharply on poster or presentation content, particularly around ophthalmology, dermatology and cell therapy gatherings of the sort listed here. The bank and broker appearances at the digital assets summit fit the established pattern of incumbents signalling tokenization intent without committing balance sheet; comparable remarks from large dealers have typically been thematic rather than stock-specific catalysts. Presentations in this format rarely include prepared disclosures beyond what is already public, so the information risk concentrates in Q&A and in any concurrent filings or abstracts. The items worth noting are the clinical-stage names presenting data-adjacent material rather than the highlighted large-cap presence.